Stocks and Finance

Roche

Roche 2/8/2012

06:32 : Roche digs in for long fight for Illumina - Swiss drugmaker Roche is digging in for a long fight after gene sequencing company Illumina rejected its $5.7 billion (3.5 billion pounds) hostile takeover bid as inadequate and said it would be more successful on its own.
Source : ibtimes-com

Roche 2/1/2012

08:20 : Roche hopeful for Illumina deal, new products - BASEL (Reuters) - Swiss drugmaker Roche Holding AG , bidding $5.7 billion for U.S. gene sequencing company Illumina , pinned its hopes on new products to drive growth this year after reporting a 4...
Source : reuters-com
08:03 : Roche brushes off waning sales to post profit gain - GENEVA (AP) -- Swiss drug maker Roche Holding AG posted a 7 percent increase in its full-year profits as lower costs offset adverse exchange rate effects and falling sales....
Source : usnews-com
03:54 : Europe up, led by oil stocks, Infineon, ICAP - MADRID (MarketWatch) -- European stock markets opened higher on Wednesday, with banks and oil stocks leading gains as investors await euro-zone manufacturing data due later. The Stoxx Europe 600 index rose 0.5% to 255.73, with Energy Stocks|energy ...
Source : marketwatch-com

Roche 1/26/2012

14:14 : Illumina adopts poison pill to stave off Roche - PHILADELPHIA/ZURICH (Reuters) - Gene sequencing company Illumina adopted a "poison pill" defense strategy against a hostile $5.7 billion bid from Swiss drugmaker Roche , saying it would trigger a...
Source : reuters-com
09:28 : Illumina unveils poison pill to stave off Roche - ZURICH (Reuters) - U.S. gene sequencing company Illumina on Thursday unveiled a "poison pill" defense strategy against a hostile bid from Swiss drugmaker Roche , saying it would trigger a rights...
Source : reuters-com
08:40 : Illumina adopts takeover defense to ward off Roche - SAN DIEGO (AP) -- Diagnostics company Illumina Inc. said Thursday that it is adopting a "poison pill" takeover defense in the wake of an unsolicited buyout overture by Swiss drugmaker Roche....
Source : usnews-com
08:23 : Illumina (ILMN) adopts a poison pill in a bid to stop a takeover by Roche ... - Illumina (ILMN) adopts a poison pill in a bid to stop a takeover by Roche (RHHBY.PK). The rights plan is triggered if a 15% ownership target is hit. Shares of ILMN -1.5%. Post your comment!
Source : seekingalpha-com

Roche 1/25/2012

22:53 : Roche Makes Risky Bet on Gene Sequencing - With its $6 billion hostile offer for Illumina Inc., Swiss drug-giant Roche Holding AG is making an expensive and risky bet that genetic mapping will soon be common practice in doctors offices and hospitals.
Source : wsj-com
18:55 : Dealtalk: Roche, Illumina hunker down for takeover battle - LOS ANGELES/PHILADELPHIA (Reuters) - Roche Holding AG's hostile bid for Illumina Inc , the market leader in gene sequencing technology, is likely to be a protracted battle lasting well into 2012...
Source : reuters-com
12:47 : Roche Offers $5.7 Billion for Illumina - Roche Holding AG (ROG) offered $5.7 billion in a hostile bid for Illumina Inc. (ILMN) to bolster sales of gene-mapping equipment and services. The tar...
10:11 : The hostile bid from Roche to take over Illumina spills over to more names - The hostile bid from Roche to take over Illumina spills over to more names (previous: PACB, GNOM, LIFE) on M&A speculation - as Sequenom (SQNM +2.2%), Qiagen (QGEN +1.5%), and Luminex (LMNX +1.1%) ...
Source : seekingalpha-com
08:24 : Roche Offers $5.7B, Unsolicited, for Illumina - Roche Holding AG is offering $5.7 billion in cash to buy U.S. gene sequencing company Illumina Inc in an unfriendly takeover bid that marks a major play by the Swiss drugmaker into the gene technology field.
Source : ibtimes-com
08:02 : DealBook: Roche Makes $5.7 Billion Bid for Illumina - Roche, the Swiss drug company, made the hostile bid for Illumina, a provider of genetic analysis services, after months of failed efforts to begin deal talks.
Source : iht-com
03:58 : Roche Bids for Gene Company - Swiss drug giant Roche made a hostile offer for Illumina that values the DNA sequencing company at $5.7 billion, underscoring growing interest in the competitive field of gene sequencing.
Source : wsj-com
03:46 : Roche offers $5.7 billion to buy gene firm Illumina - (Reuters) - Roche Holding AG is offering $5.7 billion in cash to buy U.S. gene sequencing company Illumina Inc in a hostile takeover bid that marks a major play by the Swiss drugmaker into the gene technology field.
Source : reuters-com
02:07 : Roche offers to buy Illumina for about $5.7 billion - (Reuters) - Swiss drugmaker Roche Holding AG offered about $5.7 billion in cash to buy U.S. gene sequencing device maker Illumina Inc , in a potentially hostile takeover bid to boost its position in...
Source : reuters-com
00:25 : Roche Offers $5.7 Billion for Gene Company Illumina - Swiss drug giant Roche made a hostile offer for Illumina that values the DNA sequencing company at $5.7 billion, underscoring growing interest in the competitive field of gene sequencing.
Source : wsj-com

Roche 1/24/2012

23:36 : DealBook: Roche Bids $5.7 Billion for Illumina - Roche, the Swiss drug company, made the hostile bid for Illumina, a provider of genetic analysis services, after months of failed efforts to begin deal talks.
Source : nytimes-com
22:50 : Roche (RHHBY.PK) is offering $44.50/share (about $5.7B) in cash in a hosti - Roche (RHHBY.PK) is offering $44.50/share (about $5.7B) in cash in a hostile bid to acquire DNA-tech Illumina (ILMN) - about a 23% premium over ILMN's Tuesday close, and a 64% premium to ILMN's price on Dec. 21, when takeover ...
Source : seekingalpha-com
22:29 : Roche offering $5.7 billion for Illumina - HONG KONG (MarketWatch) -- Health-care and pharmaceutical group Roche Holding AG said Wednesday it was offering approxiamtely $5.7 billion cash for all outstanding shares of DNA-technology firm Illunina Inc. , or $44.50 per share. The offer ...
Source : marketwatch-com

Roche 1/13/2012

06:21 : Advanced Explorations Files NI 43-101 Inferred Resource Estimate for Tuktu - TORONTO, ONTARIO--(Marketwire - Jan. 13, 2012) - Advanced Explorations Inc. (the "Company" or "AEI") (TSX VENTURE:AXI)(FRANKFURT:AE6) is pleased to announce the SEDAR filing of the National Instrument (NI) 43-101 compliant mineral resource estimate for ...
Source : marketwire-com

Roche 12/28/2011

14:03 : Stornoway Announces Filing of the Renard Environmental and Social Impact ... - VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 28, 2011) - Stornoway Diamond Corporation (TSX:SWY) is pleased to announce the completion and filing of an Environmental and Social Impact Assessment (ESIA) for the Renard Diamond Project located in North ...
Source : marketwire-com

Roche 12/23/2011

13:04 : Europe Markets: Europe stocks log gains ahead of holidays - European stocks advance to cap off a bullish week, led by Roche and BP, although trading volumes are light ahead of the long holiday weekend and bond yields tick higher in Italy.
Source : marketwatch-com

Roche 12/22/2011

06:41 : Roche (RHHBY.PK) CEO Severin Schwan says the Swiss drugmaker is open to ... - Roche (RHHBY.PK) CEO Severin Schwan says the Swiss drugmaker is open to an M&A of more than $3B, as well as to smaller purchases also. Schwan want deals that would fit Roche's focus on medicines which can be sold with diagnostic tools that ...
Source : seekingalpha-com

Roche 12/8/2011

17:02 : 'We are rejecting this in negotiations,' goes the actual quote from the ... - "We are rejecting this in negotiations," goes the actual quote from the German source torpedoing the idea of the ESM being granted a banking license. "No fiscal union. No e-bonds. No ECB bazooka. Crisis on folks," says Cullen ...
Source : seekingalpha-com
15:35 : Shares of Roche ([[RHHBY]] +0.7%) and Novartis ([[NVS]] -0.1%) outperform - Shares of Roche (RHHBY +0.7%) and Novartis (NVS -0.1%) outperform the general market today, after a report released late yesterday at the San Antonio Breast Cancer Symposium showed that drugs the two companies are developing ...
Source : seekingalpha-com

Roche 12/2/2011

17:29 : Not only is Europe's money supply delfating, Shadow Stats estimates real ... - Not only is Europe's money supply delfating, Shadow Stats estimates real U.S. M3 growth remains well below its ~3% historical trend. So why are we still dealing with inflation' Cullen Roche blames China, noting Chinese M2 has ...
Source : seekingalpha-com

Roche 12/1/2011

10:42 : Swiss stocks rally, led by Novartis, Roche - LONDON (MarketWatch) -- The Swiss stock market rallied on Thursday, boosted by solid gains for pharmaceutical firms. The SMI index rose 1.3% to 5,728. Shares in drug firm Roche Holding AG jumped 2.3%, while Novartis AG was ...
Source : marketwatch-com

Roche 11/18/2011

11:28 : FDA Revokes Avastin Approval for Breast Cancer - The FDA said Friday it is removing the approval of Roche Holding's drug Avastin as a breast cancer treatment because it isn't safe and effective for that type of cancer.
Source : wsj-com
actualidad Roche -
Logo Roche

Roche by date


Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts